Decay accelerating factor (CD55).
Nicholson-Weller
A
A
Beth Israel Hospital, Boston, MA 02215.
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D018958:CD55 Antigens; D003176:Complement C3 / Q000378:metabolism; D003169:Complement Inactivator Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D003170:Complement Pathway, Alternative; D006031:Glycosylation; D017261:Glycosylphosphatidylinositols / Q000378:metabolism; D006457:Hemoglobinuria, Paroxysmal / Q000378:metabolism; D006801:Humans; D008322:Mammals / Q000235:genetics / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D011499:Protein Processing, Post-Translational; D012326:RNA Splicing; D012550:Schistosoma mansoni / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D013045:Species Specificity; D014349:Trypanosoma cruzi / Q000235:genetics / Q000378:metabolism
D015703:Antigens, CD; D018958:CD55 Antigens; D003176:Complement C3; D003169:Complement Inactivator Proteins; D017261:Glycosylphosphatidylinositols; D008562:Membrane Glycoproteins